SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal...

6
SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 1 Donna Godward Chief Quality Officer Johnson & Johnson Medical Devices & Diagnostics Medical Device Quality Enhancement An Industry Perspective

Transcript of SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal...

Page 1: SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 1 Donna Godward Chief Quality Officer Johnson.

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000

Confidential.  For J&J internal use only. | 1

Donna GodwardChief Quality OfficerJohnson & JohnsonMedical Devices & Diagnostics

Medical Device Quality EnhancementAn Industry Perspective

Page 2: SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 1 Donna Godward Chief Quality Officer Johnson.

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000

Confidential.  For J&J internal use only. | 2

Goal• To improve product safety and

quality, at lower total quality cost

Engagement:• How can Industry and FDA interact to

identify way to focus on Quality

Medical Device Quality EnhancementAn Industry Perspective

Page 3: SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 1 Donna Godward Chief Quality Officer Johnson.

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000

Confidential.  For J&J internal use only. | 3

Medical Device Quality Enhancement: An Industry Perspective

• Clear priorities, aligned goals and objectives– Shifting the focus to quality from compliance– Evolve regulatory models to promote device quality

and aligning industry and FDA to “Focus on Quality”

– Achieve a preventative model with agreed Risk-Benefit framework

– Improve our ability to measure quality and early indicators

– Improve education and awareness within industry, – Clarify and communicate the “Case for Quality”– Identification and validation of Quality practices

Page 4: SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 1 Donna Godward Chief Quality Officer Johnson.

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000

Confidential.  For J&J internal use only. | 4

Medical Device Quality Enhancement: An Industry Perspective

• FDA and Industry engagement– Coalition for

• Enhancing medical device quality• Transparency• Engagement

– Work streams• Risk-benefit decision making• Quality benchmarking, CTQ & root cause• National and Local forum planning

Page 5: SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 1 Donna Godward Chief Quality Officer Johnson.

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000

Confidential.  For J&J internal use only. | 5

• Leadership from FDA and Medical Device companies

• Strong foundation for “productive relationships”

• Dialogue between FDA and Medical Device companies

• Focus on Quality

Medical Device Quality EnhancementAn Industry Perspective

Page 6: SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000 Confidential. For J&J internal use only. | 1 Donna Godward Chief Quality Officer Johnson.

SUBGROUP NAME: REGION AND/OR PROJRCT | Confidential | Month 00, 0000

Confidential.  For J&J internal use only. | 6

Medical Device Quality EnhancementAn Industry Perspective

Thank you